• No results found

Table 4:

N/A
N/A
Info
Downloaden
Protected

Academic year: 2021

Share "Table 4:"

Copied!
1
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Download het nu ( 1 pagina )

Hele tekst

(1)

Table 4: Association between change in disease activity and change in PCS

between baseline and one year (n=161).

∆PCS

n β 95%CI p-value

Model stratified for gender (p=0.056 for the interaction) Male

∆ASDAS 86 -11.0 -13.7; -8.4 <0.001

Female

∆ASDAS 75 -7.7 -9.9; -5.5 <0.001

Model stratified for job-type (p=0.077 for the interaction)a White collar

∆ASDAS 61 -9.6 -12.3; -7.0 <0.001

Blue collar

∆ASDAS 18 -15.6 -23.0; -8.3 <0.001

Results are corrected for age and stratified in case of effect

modification p<0.10. PCS, Physical Component Summary; β, beta; CI, confidence interval; ASDAS, Ankylosing Spondylitis Disease Activity Score. a 79 patients of 129 working patients provided information about profession.

Referenties

Download het nu ( PDF - 1 pagina - 630.67 KB )

GERELATEERDE DOCUMENTEN

Table 2:

BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; SD, standard deviation; CRP, C-reactive protein; ASDAS, Ankylosing Spondylitis Disease Activity Index; SF-36, 36-item

China: The Rogue Donor. An analysis of aid allocation policies of an emerging donor.

Developing countries with certain economic characteristics were indeed more likely to receive aid from China, though this evidence is less convincing than for the

Development of the CT Syndesmophyte Score (CTSS) in patients with ankylosing spondylitis: data from the SIAS cohort

For patients that were included in the analysis, missing scores were imputed using a previously described adaptation of the last-observation-carried-forward method.[7] Briefly,

Development of the CT Syndesmophyte Score (CTSS) in patients with ankylosing spondylitis: data from the SIAS cohort

The percentage of quadrants per side of a vertebral unit (posterior, anterior, left or right) affected by syndesmophytes relative to the total number of quadrants per side for

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological diseasemodifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 ran

Abbreviations: ASAS-HI = Assessment of Spondyloarthritis International Society Health Index; ASDAS IN = ASDAS Ankylosing Spondylitis Disease Activity Score Inactive Disease; CFB

Characterization of Patients With Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis in the US-Based Corrona Registry

• In this analysis of patients with axial spondyloarthri- tis in the US-based Corrona Psoriatic Arthritis/ Spondyloarthritis Registry, we observed no differ- ences between patients

Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states

The Ankylosing Spondylitis Disease Activity Score (ASDAS) is a measure of axial spondyloarthritis (axSpA) disease activity with validated cut-offs endorsed by the Assessment

Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis

ASAS HI= ASAS Health Index; ASDAS=Ankylosing Spondylitis Disease Activity Index; BASDAI= Bath Ankylosing Spondylitis Disease Activity Index; BASFI=Bath Ankylosing Spondylitis